JPMorgan Chase & Co. Trims Holdings in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV)
JPMorgan Chase & Co. lessened its holdings in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Free Report) by 6.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 21,260 shares of the specialty pharmaceutical company’s stock after selling 1,350 shares during the period. JPMorgan Chase & Co.’s holdings in KalVista Pharmaceuticals were worth $180,000 as […]
JPMorgan Chase & Co. lessened its holdings in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Free Report) by 6.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 21,260 shares of the specialty pharmaceutical company’s stock after selling 1,350 shares during the period. JPMorgan Chase & Co.’s holdings in KalVista Pharmaceuticals were worth $180,000 as […]
